Avalo Therapeutics, Inc. Liquidation Value
AVTX
Other
Cash & Equivalents
$15.86M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $15.86M
Total Obligations: -$13.37M
$2.49M
Per share: $0.13
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $15.86M
AR: $0
Total Obligations: -$13.37M
$2.49M
Per share: $0.13
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $15.86M
AR: $0
Inventory: $0
Total Obligations: -$13.37M
$2.49M
Per share: $0.13
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $2.49M | $0.13 |
| Liquid Liquidation Value | $2.49M | $0.13 |
| Operating Liquidation Value | $2.49M | $0.13 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $15.86M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $12.94M |
| Long-term Debt | N/A |
| Op. Lease Liability | $427,000 |
| Finance Lease | N/A |
| Shares Outstanding | 18.5M |
Explore all 149 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $15.86M | N/A | N/A | $137,000 | $12.94M | N/A | $427,000 | N/A |
| 2025-09-30 | $26.96M | N/A | N/A | $474,000 | $7.97M | N/A | $555,000 | N/A |
| 2025-06-30 | $42.29M | N/A | N/A | $2.37M | $9.26M | N/A | $679,000 | N/A |
| 2025-03-31 | $125.05M | N/A | N/A | $681,000 | $5.62M | N/A | $801,000 | N/A |
▼ Community Notes